Education, Science, Technology, Innovation and Life
Open Access
Sign In

High-throughput screening of medical disease biomarkers and the evaluation of their value in early diagnosis

Download as PDF

DOI: 10.23977/medbm.2024.020213 | Downloads: 21 | Views: 753

Author(s)

Yuheng Zhang 1, Jiaqi Ren 1, Runxiu Chen 1, Han Wang 1

Affiliation(s)

1 College of Medical, Shihezi University, Shihezi, Xinjiang, China

Corresponding Author

Yuheng Zhang

ABSTRACT

Internal medicine diseases pose a major threat to global health, and early diagnosis is the key to improving treatment effectiveness. This study used high-throughput screening techniques to successfully identify potential biomarkers associated with the occurrence and development of internal diseases. Early detection of these biomarkers offers new possibilities for disease diagnosis, and their expression levels are closely associated with the disease process. The study also analyzes the advantages and limitations of high-throughput screening technology and proposes corresponding improvement strategies. Despite progress in the screening and evaluation of biomarkers, challenges are needed to improve technical sensitivity, specificity and translation of clinical applications. Future studies are needed to further explore the clinical application potential of these biomarkers and to develop more precise and efficient diagnostic methods.

KEYWORDS

Biomarkers, high-throughput screening, early diagnosis, medical diseases

CITE THIS PAPER

Yuheng Zhang, Jiaqi Ren, Runxiu Chen, Han Wang, High-throughput screening of medical disease biomarkers and the evaluation of their value in early diagnosis. MEDS Basic Medicine (2024) Vol. 2: 90-95. DOI: http://dx.doi.org/10.23977/medbm.2024.020213.

REFERENCES

[1] Yarmey R V, Miguel S A. Biomarkers for aging in Caenorhabditis elegans high throughput screening.[J]. Biochemical Society transactions, 2024
[2] Ren Dandan. Application of a new method for fluorescence sensing based on nanomaterials in biomarker detection [D]. Nanjing Medical University, 2023.
[3] Li Qiong, Zhang Yan. Progress in investigating the role of circulating free nucleic acids as epigenetic markers in precision medicine [J]. Modern Medicine and Health, 2022, 38 (22): 3849-3853 + 3857.
[4] Han Shanying. Cancer biomarkers screening based on extracellular vesicle proteomics techniques [D]. Southeastern University, 2022.
[5] Fu Qiang, Deng Xiaofang, Akindavyi Gael, et al. Study on biomarkers for screening of aortic dissection by high-throughput technology [J]. Journal of Clinical Cardiovascular Diseases, 2021, 37 (10): 952-958.
[6] Wang Hongyang. Tumor biomarker development in the era of precision medicine [J]. Journal of Shandong University (Medical edition), 2018,56 (10): 1-2.
[7] Yu Li. Study on metabolic characteristics and early diagnosis of small cell lung cancer based on new-generation metabolomics techniques [D]. China Medical University, 2018.
[8] A G M, Michelangelo C, Umberto G. Responsible Precision Medicine in Pediatric Acute Respiratory Distress Syndrome: The Challenge of Searching for Biomarker-Driven Earlier Diagnosis, Effective Treatment, and Stratified Outcomes.[J].Critical care medicine, 2018, 46(1):172-174.
[9] Zhu Minhui, Zheng Hongliang. New progress in the early diagnosis of head and neck tumors in the era of precision medicine [J]. Journal of Clinical Otolaryngology, Head and Neck Surgery, 2017, 31 (22): 1770-1774.

Downloads: 1586
Visits: 78183

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.